salicylic acid has been researched along with Colorectal Neoplasms in 16 studies
Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
Excerpt | Relevance | Reference |
---|---|---|
"Salicylic acid (SA) has observationally been shown to decrease colorectal cancer (CRC) risk." | 8.02 | Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study. ( Albanes, D; Alwers, E; Amitay, E; Baron, JA; Bermejo, JL; Berndt, SI; Bishop, DT; Brenner, H; Buchanan, DD; Butterworth, A; Campbell, PT; Casey, G; CastellvĂ-Bel, S; Chan, AT; Chang-Claude, J; Drew, DA; Figueiredo, JC; Gallinger, S; Giles, GG; Gruber, SB; Gsur, A; Gunter, MJ; Hampel, H; Harrison, TA; Hoffmeister, M; Hopper, JL; Keku, TO; Kim, HR; Kweon, SS; Li, CI; Li, L; Lin, Y; Lindblom, A; Lindor, NM; Marchand, LL; Moreno, V; Newcomb, PA; Nounu, A; Peters, U; Pharoah, PDP; Platz, EA; Relton, CL; Rennert, G; Richmond, RC; Sakoda, LC; Schafmayer, C; Scherer, D; Schoen, RE; Slattery, ML; Stadler, ZK; Stewart, ID; Surendran, P; Ulrich, CM; van Dujinhoven, FJB; Van Guelpen, B; Vodicka, P; Vodickova, L; Wareham, NJ; Weinstein, SJ; White, E; Williams, AC; Wolk, A; Woods, MO; Wu, AH; Zheng, W, 2021) |
"Aspirin's potential as a drug continues to be evaluated for the prevention of colorectal cancer (CRC)." | 7.85 | Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer. ( Bhat, GJ; Callegari, E; Dachineni, R; Kesharwani, SS; Kumar, DR; Sankaranarayanan, R; Seefeldt, T; Tummala, H, 2017) |
"Aspirin was introduced into clinical practice more than 100 years ago." | 6.41 | Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer. ( Lawrence, JR; Paterson, JR, 2001) |
"Aspirin has recently been attracting attention as a cancer preventive drug, and its inhibitory effects on the development of various cancers have been reported in several large prospective studies." | 5.72 | Salicylic acid directly binds to ribosomal protein S3 and suppresses CDK4 expression in colorectal cancer cells. ( Aono, Y; Horinaka, M; Iizumi, Y; Imai, A; Ishikawa, H; Mutoh, M; Nishimoto, E; Ono, H; Sakai, T; Takakura, H; Taniguchi, K; Yasuda, S, 2022) |
"Intake of acetylsalicylic acid reduces the risk of cardiovascular disease and is associated with a decreased risk for colorectal cancer." | 5.08 | Urinary salicylate excretion in subjects eating a variety of diets shows that amounts of bioavailable salicylates in foods are low. ( Hollman, PC; Janssen, PL; Katan, MB; Reichman, E; van Staveren, WA; Venema, DP, 1996) |
"A variety of studies have supported the finding that regular intake of aspirin (acetylsalicylic acid) or nonsteroidal anti-inflammatory agents can affect colorectal cancer carcinogenesis." | 5.08 | Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. ( Boland, CR; Brenner, DE; Crowell, J; Kelloff, G; Krishnan, K; Normolle, D; Peters-Golden, M; Rock, CL; Ruffin, MT; Vaerten, MA, 1997) |
"Salicylic acid (SA) has observationally been shown to decrease colorectal cancer (CRC) risk." | 4.02 | Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study. ( Albanes, D; Alwers, E; Amitay, E; Baron, JA; Bermejo, JL; Berndt, SI; Bishop, DT; Brenner, H; Buchanan, DD; Butterworth, A; Campbell, PT; Casey, G; CastellvĂ-Bel, S; Chan, AT; Chang-Claude, J; Drew, DA; Figueiredo, JC; Gallinger, S; Giles, GG; Gruber, SB; Gsur, A; Gunter, MJ; Hampel, H; Harrison, TA; Hoffmeister, M; Hopper, JL; Keku, TO; Kim, HR; Kweon, SS; Li, CI; Li, L; Lin, Y; Lindblom, A; Lindor, NM; Marchand, LL; Moreno, V; Newcomb, PA; Nounu, A; Peters, U; Pharoah, PDP; Platz, EA; Relton, CL; Rennert, G; Richmond, RC; Sakoda, LC; Schafmayer, C; Scherer, D; Schoen, RE; Slattery, ML; Stadler, ZK; Stewart, ID; Surendran, P; Ulrich, CM; van Dujinhoven, FJB; Van Guelpen, B; Vodicka, P; Vodickova, L; Wareham, NJ; Weinstein, SJ; White, E; Williams, AC; Wolk, A; Woods, MO; Wu, AH; Zheng, W, 2021) |
"Aspirin's potential as a drug continues to be evaluated for the prevention of colorectal cancer (CRC)." | 3.85 | Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer. ( Bhat, GJ; Callegari, E; Dachineni, R; Kesharwani, SS; Kumar, DR; Sankaranarayanan, R; Seefeldt, T; Tummala, H, 2017) |
"Aspirin was introduced into clinical practice more than 100 years ago." | 2.41 | Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer. ( Lawrence, JR; Paterson, JR, 2001) |
"Aspirin has recently been attracting attention as a cancer preventive drug, and its inhibitory effects on the development of various cancers have been reported in several large prospective studies." | 1.72 | Salicylic acid directly binds to ribosomal protein S3 and suppresses CDK4 expression in colorectal cancer cells. ( Aono, Y; Horinaka, M; Iizumi, Y; Imai, A; Ishikawa, H; Mutoh, M; Nishimoto, E; Ono, H; Sakai, T; Takakura, H; Taniguchi, K; Yasuda, S, 2022) |
"Evidence for cancer prophylaxis is based on ASA doses of at least 75mg/day." | 1.43 | Aspirin for cancer is no mere antiplatelet prototype. There is potential in its ancient roots. ( Baxter, GJ; Lawrence, JR; Paterson, JR, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (37.50) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 6 (37.50) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors | Studies |
---|---|
Nounu, A | 1 |
Richmond, RC | 1 |
Stewart, ID | 1 |
Surendran, P | 1 |
Wareham, NJ | 1 |
Butterworth, A | 1 |
Weinstein, SJ | 1 |
Albanes, D | 1 |
Baron, JA | 2 |
Hopper, JL | 1 |
Figueiredo, JC | 1 |
Newcomb, PA | 1 |
Lindor, NM | 1 |
Casey, G | 1 |
Platz, EA | 1 |
Marchand, LL | 1 |
Ulrich, CM | 1 |
Li, CI | 1 |
van Dujinhoven, FJB | 1 |
Gsur, A | 1 |
Campbell, PT | 1 |
Moreno, V | 1 |
Vodicka, P | 1 |
Vodickova, L | 1 |
Amitay, E | 1 |
Alwers, E | 1 |
Chang-Claude, J | 1 |
Sakoda, LC | 1 |
Slattery, ML | 1 |
Schoen, RE | 1 |
Gunter, MJ | 1 |
CastellvĂ-Bel, S | 1 |
Kim, HR | 1 |
Kweon, SS | 1 |
Chan, AT | 1 |
Li, L | 1 |
Zheng, W | 1 |
Bishop, DT | 1 |
Buchanan, DD | 1 |
Giles, GG | 1 |
Gruber, SB | 1 |
Rennert, G | 1 |
Stadler, ZK | 1 |
Harrison, TA | 1 |
Lin, Y | 1 |
Keku, TO | 1 |
Woods, MO | 1 |
Schafmayer, C | 1 |
Van Guelpen, B | 1 |
Gallinger, S | 1 |
Hampel, H | 1 |
Berndt, SI | 1 |
Pharoah, PDP | 1 |
Lindblom, A | 1 |
Wolk, A | 1 |
Wu, AH | 1 |
White, E | 1 |
Peters, U | 1 |
Drew, DA | 1 |
Scherer, D | 1 |
Bermejo, JL | 1 |
Brenner, H | 1 |
Hoffmeister, M | 1 |
Williams, AC | 1 |
Relton, CL | 1 |
Imai, A | 1 |
Horinaka, M | 1 |
Aono, Y | 1 |
Iizumi, Y | 1 |
Takakura, H | 1 |
Ono, H | 1 |
Yasuda, S | 1 |
Taniguchi, K | 1 |
Nishimoto, E | 1 |
Ishikawa, H | 1 |
Mutoh, M | 1 |
Sakai, T | 1 |
Dachineni, R | 1 |
Kumar, DR | 1 |
Callegari, E | 1 |
Kesharwani, SS | 1 |
Sankaranarayanan, R | 1 |
Seefeldt, T | 1 |
Tummala, H | 1 |
Bhat, GJ | 1 |
Lawrence, JR | 2 |
Baxter, GJ | 1 |
Paterson, JR | 2 |
Shaukat, A | 1 |
Grau, MV | 1 |
Church, TR | 1 |
Baxter, G | 1 |
Barry, EL | 1 |
Summers, R | 1 |
Sandler, RS | 1 |
Owen, RW | 1 |
Wimonwatwatee, T | 1 |
Spiegelhalder, B | 1 |
Bartsch, H | 1 |
Janssen, PL | 1 |
Hollman, PC | 1 |
Reichman, E | 1 |
Venema, DP | 1 |
van Staveren, WA | 1 |
Katan, MB | 1 |
Ruffin, MT | 1 |
Krishnan, K | 1 |
Rock, CL | 1 |
Normolle, D | 1 |
Vaerten, MA | 1 |
Peters-Golden, M | 1 |
Crowell, J | 1 |
Kelloff, G | 1 |
Boland, CR | 1 |
Brenner, DE | 1 |
Giardina, C | 1 |
Boulares, H | 1 |
Inan, MS | 1 |
Scheier, L | 1 |
Shah, SR | 1 |
Applebaum, DS | 1 |
Potenziani, S | 1 |
Huttenbach, YT | 1 |
Wolf, J | 1 |
Orengo, IF | 1 |
Rogers, JE | 1 |
Ohinata, A | 1 |
Dasari, A | 1 |
Eng, C | 1 |
Ha, JY | 1 |
Oh, EH | 1 |
Jung, MK | 1 |
Park, SE | 1 |
Kim, JT | 1 |
Hwang, IG | 1 |
Lee, M | 1 |
Duke, EE | 1 |
Munoz, J | 1 |
Holaday, L | 1 |
Sgouros, S | 1 |
Walsh, AR | 1 |
2 reviews available for salicylic acid and Colorectal Neoplasms
Article | Year |
---|---|
Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; Cyclooxygenase Inhibitors; D | 2001 |
Colorectal cancer presenting with a cutaneous metastatic lesion on the scalp.
Topics: Adenocarcinoma; Colorectal Neoplasms; Diagnosis, Differential; Humans; Male; Middle Aged; Scalp; Ski | 1995 |
3 trials available for salicylic acid and Colorectal Neoplasms
Article | Year |
---|---|
Serum salicylate levels and risk of recurrent colorectal adenomas.
Topics: Adenoma; Calcium, Dietary; Colorectal Neoplasms; Dietary Supplements; Female; Humans; Male; Middle A | 2011 |
Urinary salicylate excretion in subjects eating a variety of diets shows that amounts of bioavailable salicylates in foods are low.
Topics: Adult; Biological Availability; Cardiovascular Diseases; Colorectal Neoplasms; Diet; Female; Humans; | 1996 |
Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colon; Colorectal Neoplasms; Drug Administr | 1997 |
11 other studies available for salicylic acid and Colorectal Neoplasms
Article | Year |
---|---|
Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study.
Topics: Aspirin; Case-Control Studies; Colorectal Neoplasms; Diet; Female; Genome-Wide Association Study; Ge | 2021 |
Salicylic acid directly binds to ribosomal protein S3 and suppresses CDK4 expression in colorectal cancer cells.
Topics: Aspirin; Colorectal Neoplasms; Cyclin-Dependent Kinase 4; Humans; Prospective Studies; Ribosomal Pro | 2022 |
Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
Topics: Acetylation; Anticarcinogenic Agents; Aspirin; CDC2 Protein Kinase; Colorectal Neoplasms; Cyclin B1; | 2017 |
Aspirin for cancer is no mere antiplatelet prototype. There is potential in its ancient roots.
Topics: Animals; Aspirin; Blood Platelets; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Gastrointestinal | 2016 |
A high performance liquid chromatography system for quantification of hydroxyl radical formation by determination of dihydroxy benzoic acids.
Topics: Chromatography, High Pressure Liquid; Colorectal Neoplasms; Humans; Hydroxybenzoates; Hydroxyl Radic | 1996 |
NSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: the role of reactive oxygen species.
Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Antioxidants; Apoptosis; Butyra | 1999 |
Salicylic acid: one more reason to eat your fruits and vegetables.
Topics: Arteriosclerosis; Cardiovascular Diseases; Colorectal Neoplasms; Condiments; Diet, Vegetarian; Food | 2001 |
Cutaneous metastasis to the scalp as the primary presentation of colorectal adenocarcinoma.
Topics: Adenocarcinoma; Biopsy; Colorectal Neoplasms; CREST Syndrome; Female; Head and Neck Neoplasms; Human | 2017 |
Atypical metastatic presentations in colorectal cancer: a case series.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Female; Humans; Male; Mandibular Neoplasms; Pancr | 2014 |
Choroidal and skin metastases from colorectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Biopsy; Capecitabine; C | 2016 |
Synchronous dural and cutaneous metastases along the distribution of the external carotid artery.
Topics: Adult; Carotid Artery, External; Cerebellar Neoplasms; Colorectal Neoplasms; Dura Mater; Humans; Mal | 1994 |